Ziopharm Oncology and TriArm Therapeutics establish JV in China, Taiwan and Korea
Ziopharm Oncology and TriArm Therapeutics announced they will launch Eden BioCell, Ltd. to lead clinical development and commercialization of Sleeping Beauty-generated CAR-T therapies in the People’s Republic of China (including Macau and Hong Kong), Taiwan and Korea. December 19, 2018